dr lee newcomer on value calculators and new immuno-oncology agents
Published 8 years ago • 68 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:31
dr lee newcomer on policy decisions as new immunotherapy agents are developed
-
1:06
dr lee newcomer on unitedhealthcare’s value-based contracts
-
1:19
dr lee newcomer: comparison data is necessary for more accurate results
-
0:56
dr lee newcomer: partnership is key in episode-based payments
-
1:25
dr lee newcomer discusses payer strategies in population health management
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
1:00:50
deciphering immuno-oncology: targeting innate immunity in cancer
-
1:33:02
immuno-oncology: a future look
-
1:49
dr lee newcomer addresses the differences between unitedhealthcare and cms' payment models
-
34:47
immuno-oncology, immune therapy, pd-1 in melanoma - omid hamid md
-
5:20
immuno-oncology agents for mm: checkpoint inhibitors and nk-cells
-
15:37
10/30/18 - session 5: newcomer
-
0:15
activated t cell attacks a cancer cell
-
2:55
value benchmarks in immuno-oncology
-
45:30
current and novel immuno-oncology drug evaluation methods via humanized mouse models
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
5:11
3/1/2016 - session 6: newcomer
-
1:01
year one of our pelotonia institute for immuno-oncology
-
1:35
dr. lee on the combination of immunotherapy and tkis in mrcc
-
2:09
advances in predictive biomarkers for immuno-oncology agents
-
45:27
irrc: variations in i-o response patterns and implications for treatment
-
32:57
next generation targets for immuno-oncology